Pancreatic Cancer Conference 2014 Teleconferences
The AACR hosted two press teleconferences during its special conference on Pancreatic Cancer: Innovations in Research and
Treatment, May 18-21, 2014, in New Orleans.
Monday, May 19: This
teleconference highlights the following research:
- Pancreatic Cancer Projected to Become Second Leading Cause of Cancer-related Death in the United States by 2030;
- Radioimmunotherapy and Gemcitabine Combination Shows Early Promise for Metastatic Pancreatic Ductal Cancer;
- New Blood-based Biomarker Panel May Enable Pancreatic Cancer Diagnosis at an Early Stage; and
- Potential New Therapeutic Approach Identified for Two Types of Pancreatic Cancer.
Wednesday, May 21: Conference
leaders David Tuveson, M.D., Ph.D., The Lustgarten Foundation and ColdSpring
Harbor Laboratories; Christine Iacobuzio-Donahue, M.D., Memorial Sloan Kettering
Cancer Center; and Alec Kimmelman, M.D., Ph.D., Dana-Farber Cancer Institute,
offer analysis of the conference, including discussion of new research areas and
potential treatment options.
Page updated May 21, 2014.